Cryobiology Past – Present – Future

The 50th Annual Meeting of the Society for Cryobiology, CRYO2013, will be held 28-31 July 2013 in the spacious facilities of the North Bethesda Marriott Hotel and Conference Center, just outside Washington, DC.

CRYO2013 is partnering with the International Society for Cellular Therapy (ISCT) for the Symposium Cryopreservation and Good Manufacturing Practice (GMP) – Meeting Industrial and Regulatory Demands.

Dr. Aby J. Mathew, BioLife Solutions, Inc., will be presenting on the topic, Considerations for Development of GMP Biopreservation Solutions for Regenerative Medicine, during the late morning Equipment and Consumables session, Monday July 29th.

Go to Site

September 8-11, 2013
Location: Hyatt at Penn’s Landing, Philadelphia, PA

The program will highlight the close working relationships between the academic, industry, patient care and regulatory communities. Plenary sessions will include advances in cord blood, updates on CAR-targeted T cells, MSC biology and a timely session on regulatory/accreditation changes. Other planned sessions will cover topics of interest in the areas of technical practice, manufacturing, quality, commercialization and delivery of patient care.

Go to Site

Location: London, UK
May 21-23, 2013

Dr. Aby J. Mathew, Senior Vice President & Chief Technology Officer, BioLife Solutions Inc., will be presenting on the topic: Ensuring the appropriate cryopreservation of your stem cell-based therapy.
May 23, 11:20 AM

World Stem Cells & Regenerative Medicine Congress 2013 is now into its 8th year.
It is Europe’s largest and most senior conference for the stem cell research and regenerative medicine community. 91.9% of 2012 attendees said they would positively recommend this congress to their peers in the industry. Over 65% of attendees come from the industry’s leading pharma, biotech and academic research institutes, with global representation from Europe, North America & Asia.

Go to Site

Location: San Francisco, CA
June 6-8, 2013

The international cord blood community’s flagship event connects a global network of influential stakeholders: physicians and health care professionals, scientists, educators, industry representatives, government officials, patients, and advocates.

Go to Site

Location: Cambridge, MA
September 30 – October 1, 2013

The Stem Cells & Regenerative Medicine Congress is where pharma, biotechs, academia, government and investors come to uncover the technologies, strategies and business models that will help get stem cell and regenerative medicine treatments to market faster.

Go to Site

Location: The Vatican
April 11-13, 2013

The conference speaks to an audience of scientific leaders, policymakers, ethicists, educators, Ministers of Health from around the world, ambassadors to the Holy See, and representatives of the stem cell therapeutic business community. Seating for 350 attendees is exclusive and can only obtained by invitation.

Go to Site

Location: Dublin, Ireland
April 5-6, 2013

The Biomedical Excellence for Safer Transfusion (BEST) Collaborative is an international research organization that works collaboratively to explore ways to improve transfusion-related services through standardization of analytic techniques, development of new procedures, systematic review of evidence, and execution of clinical and laboratory studies. The Irish Blood Transfusion Service will be sponsoring a Transfusion Medicine Education Forum on April 4, 2013 in Dublin, Ireland, featuring presentations by selected BEST Members.

Go to Site

Location: Auckland, New Zealand
April 22-25, 2013
Booth: 22/23

This meeting will provide the most current educational information regarding a wide range of therapies. The ISCT Annual Meeting educational objectives include:

The translational aspects of and issues involved with all types of cell and tissue-based research.
To promote cross-disciplinary participation from scientists, clinicians, laboratory personnel, regulatory professionals, and KOLs from both academia and industry.
To identify and address the scientific, clinical, laboratory, and regulatory issues related to each type of cell-based research/therapy.
A forum for the transfer of knowledge and experiences from senior practicioners and key opinion leaders to young scientists in the field.

Go to Site

January 21-23, 2013
Location: San Diego, CA

The second annual conference on Scale-Up and Manufacturing of Cell-Based Therapies is scheduled for January 21-23, 2013 and will take place at the Hyatt Regency in San Diego. This conference will focus on process development, scale-up, and manufacturing of cell-based therapies and will bring academicians, clinicians, industry leaders, and regulators from all over the world together to discuss the most critical scientific and engineering challenges in this field. It is our aim that this conference will continue to play a central role in defining and refining the engineering sciences of cell based therapies.

Go to Site

January 28-30, 2013

Location: Washington DC

Phacilitate’s 9th Annual Cell & Gene Therapy Forum is firmly established as the world’s leading strategy and partnering event for senior decision makers from the global cell therapy, gene therapy and tissue engineered product sectors.

Go To This Site